We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Mixing Muscle Relaxants and Anesthetics Raises Respiratory Risk

By HospiMedica International staff writers
Posted on 03 Oct 2018
Print article
A new study concludes that administering neuromuscular blocking drugs during general anesthesia (GA) is associated with an increased risk of postoperative pulmonary complications.

Researchers at Munich Technical University (TUM; Germany), Karolinska Institutet (KI; Solna, Sweden), the University of Liverpool (United Kingdom), and other institutions conducted a multicenter observational study to assess if neuromuscular blocking agent use is associated with postoperative pulmonary complications. To do so, they collected data from 22,803 patients who received anesthesia for any in-hospital procedure--except cardiac surgery--conducted in 211 hospitals in 28 European countries over the course of a year.

Patient characteristics, surgical and anesthetic details, and chart review at discharge were prospectively collected over two weeks. Each patient also had a postoperative physical examination within three days of surgery for adverse pulmonary events. Overall, about three quarters of all patients (17,150 people) were treated with neuromuscular blocking agents. The most common respiratory complications were a transient reduced lung capacity for oxygen absorption (5.2%), and infections of the lung and respiratory tract (2.5%).

The results showed that patients receiving neuromuscular blocking agents while under GA had a significantly higher (4.4%) risk of developing any type of respiratory complication. The study also showed that neither neuromuscular monitoring, nor the administration of reversal agents reduced the risk. The researchers are now planning to implement more targeted studies in order to identify the underlying mechanisms behind their findings. The study was published on September 14, 2018, in Lancet Respiratory Medicine.

“Neuromuscular blocking agents have made surgery considerably safer and more effective since their introduction. These drugs are particularly needed when operating on a patient's chest or abdomen. They are also used to protect the vocal cords from injury when a tube is placed in the airway to allow artificial ventilation,” said senior author Professor Manfred Blobner, MD, of TUM. “Patients undergoing minor surgical procedures that do not necessarily require neuromuscular blocking drugs might benefit from avoiding them. Using devices like laryngeal masks for anesthesia instead of tracheal tubes that go past the vocal cords could prove helpful as well.”

Related Links:
Munich Technical University
Karolinska Institutet
University of Liverpool

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Cart
UMGSA-33369-VIL

Print article

Channels

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more